Novavax Inc

Lician Pro · $19.99/mo or $149/yr · AAPL vs MSFT

Novavax Inc (NVAX) SEC filings

Novavax Inc (NVAX) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.

Those exhibit numbers sit next to the income-statement cache: Latest reported NVAX revenue for 2025-12-31 was $1.12B. Net income was $440.3M. Revenue was up 64.7% from 2024-12-31 to 2025-12-31. NVAX currently screens at market cap $1.09B. The NVAX filings page is the source view; the stock page is the research view.

EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Novavax Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.

Earnings & events

All events

Event insights for NVAX — what management said, what changed, and why it matters.

Recent filings

These filings as JSON? API free 100/day

NVAX SEC filings FAQ

What is the latest NVAX SEC filing?

The latest cached Novavax Inc (NVAX) filing on this page is 8-K · Jun 23, 2026. Filings: https://lician.com/sec/nvax

What is the latest NVAX filing accession number?

The latest cached Novavax Inc (NVAX) accession number on this page is 0001104659-26-076648. Filing: https://lician.com/sec/nvax/0001104659-26-076648

Which item code is on the latest NVAX filing?

Cached item code on the latest Novavax Inc (NVAX) 8-K is 5.07.

How many NVAX SEC filings are listed on this page?

This page lists 2 cached Novavax Inc (NVAX) SEC filings. Filings: https://lician.com/sec/nvax

What events are listed on the NVAX SEC page?

Cached event headlines on this Novavax Inc (NVAX) SEC page: "NVAX earnings". Events: https://lician.com/sec/nvax

What are NVAX's latest revenue and net income?

Latest cached Novavax Inc (NVAX) revenue for Dec 31, 2025 was $1.12B. Net income was $440.3M. Statements: https://lician.com/financials/nvax